The Albany prize was established in 2000 with a $50 million gift from the late Morris "Marty" Silverman, a New York City businessman who wanted to encourage health and biomedical research.
Their progress in the study of immunity started with Steinman in 1973. He discovered a white blood cell he named the dendritic cell. The cells act as the 911 call for the body, alerting other white blood cells to multiply and prepare a defense.
Steinman's discovery of dendritic cells and their role in immunity, has pushed research toward potential vaccine improvements, treatment of autoimmune disorders and cancer.
"It's very important to understand how your body resists infection," Steinman said.
Dinarello worked on therapies to block the immune system's inflammatory reaction when it's harmful.
Dinarello identified the molecule in the body that produces a fever, or inflammation. Since discovering that molecule, later called Interleukin-1, he's focused his work on blocking it to relieve inflammation. This, and discoveries of different Interleukins, has resulted in treatment for immune disorders, including Crohn's disease, diabetes, allergies and rheumatoid arthritis.
Beutler defined what another type of protein the dendritic cells produce does for immune systems. It's called Tumor Necrosis Factor, or TNF. He isolated TNF and explained that it also played a role in responding to inflammation.
Beutler created a medication that blocks TNF when it goes into overdrive. The medication
- brand name Enbrel - has been used to treat rheumatoid arthritis, psoriasis, and other autoimmune disorders.
